Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 1/20 | 0.41 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.41 |
| ▸ | LPO | P22079 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11050657 | 0.73 | ALDH1A1 (0.57) | KMT2AHTTKDM4E | |
| SCHEMBL2516063 | 0.73 | — | — | |
| SCHEMBL12364166 | 0.72 | CHRNB2 (0.42) | CHRNB2CHRNA4LPOKMT2AHTT | |
| SCHEMBL20195592 | 0.71 | — | — | |
| SCHEMBL2513335 | 0.70 | — | — | |
| SCHEMBL12701548 | 0.68 | CHRNB2 (0.50) | CHRNB2CHRNA4LPOKMT2AHTT | |
| Hydrochloric Acid SCHEMBL28150747 | 0.68 | CHRNB2 (0.50) | CHRNB2CHRNA4LPOKMT2AHTT | |
| Hydrochloric Acid SCHEMBL28178521 | 0.68 | CHRNB2 (0.50) | CHRNB2CHRNA4LPOKMT2AHTT | |
| SCHEMBL17115289 | 0.68 | — | — | |
| SCHEMBL27788080 | 0.68 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080300418-A1 | Synthesis of Cardiolipin Analogues and Uses Thereof | AHMAD MOGHIS U | 2008-12-04 | — | — | US | claimed |
| EP-1819715-A2 | SYNTHESIS OF CARDIOLIPIN ANALOGUES AND USES THEREOF | Neopharm, Inc. (US) | 2007-08-22 | — | — | EP | claimed |
| WO-2006052906-A2 | SYNTHESIS OF CARDIOLIPIN ANALOGUES AND USES THEREOF | NEOPHARM, INC. (US) | 2006-05-18 | — | — | WO | claimed |
| US-20050266068-A1 | Cardiolipin molecules and methods of synthesis | NEOPHARM, INC. (US) | 2005-12-01 | — | — | US | claimed |
| EP-1556392-A1 | CARDIOLIPIN MOLECULES AND METHOD OF SYNTHESIS | Neopharm, Inc. (US) | 2005-07-27 | — | — | EP | claimed |
| WO-2004039817-A9 | CARDIOLIPIN MOLECULES AND METHOD OF SYNTHESIS | NEOPHARM INC (US) | 2004-07-22 | — | — | WO | claimed |
| WO-2004039817-A1 | CARDIOLIPIN MOLECULES AND METHOD OF SYNTHESIS | NEOPHARM, INC. (US) | 2004-05-13 | — | — | WO | claimed |
| US-20080300418-A1 | Synthesis of Cardiolipin Analogues and Uses Thereof | AHMAD MOGHIS U | 2008-12-04 | — | — | US | disclosed |
| EP-1819715-A2 | SYNTHESIS OF CARDIOLIPIN ANALOGUES AND USES THEREOF | Neopharm, Inc. (US) | 2007-08-22 | — | — | EP | disclosed |
| WO-2006052906-A2 | SYNTHESIS OF CARDIOLIPIN ANALOGUES AND USES THEREOF | NEOPHARM, INC. (US) | 2006-05-18 | — | — | WO | disclosed |
| US-20050266068-A1 | Cardiolipin molecules and methods of synthesis | NEOPHARM, INC. (US) | 2005-12-01 | — | — | US | disclosed |
| EP-1556392-A1 | CARDIOLIPIN MOLECULES AND METHOD OF SYNTHESIS | Neopharm, Inc. (US) | 2005-07-27 | — | — | EP | disclosed |
| WO-2004039817-A1 | CARDIOLIPIN MOLECULES AND METHOD OF SYNTHESIS | NEOPHARM, INC. (US) | 2004-05-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050266068-A1 | Cardiolipin molecules and methods of synthesis | PHOSPHO1, MGLL, LIPA | CHRNB2 4375/4885CHRNA4 4738/4885LPO 1119/4885 |
| US-20080300418-A1 | Synthesis of Cardiolipin Analogues and Uses Thereof | PHOSPHO1, SGMS1, SGMS2 | CHRNB2 3827/4885CHRNA4 4011/4885LPO 2940/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.